PARPBP and Hypoglycemia: It would be informative to examine the role of systemic estradiol in VMN AROM expression and activity patterns during eu- versus hypoglycemia, and to ascertain if optimum neuroestradiol control of glucose-regulation necessitates coincident ER activation by gonadal estradiol.